252
Participants
Start Date
December 31, 2010
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Pitavastatin
Pitavastatin 4 mg QD
Pravastatin
Pravastatin 40 mg QD
Phoenix
Beverly Hills
Costa Mesa
Long Beach
Los Angeles
Newport Beach
San Francisco
Washington D.C.
Coral Gables
Fort Lauderdale
Ft. Pierce
Miami
Miami Beach
Tampa
Vero Beach
Atlanta
Decatur
Springfield
Berkley
St Louis
Hillsborough
Randolph Township
New York
Rochester
Huntersville
Addison
Austin
Corpus Christi
Fort Worth
Harlingen
Houston
Longview
Annandale
Seattle
Spokane
Lead Sponsor
Collaborators (1)
Kowa Pharmaceuticals America, Inc.
INDUSTRY
Eli Lilly and Company
INDUSTRY
Kowa Research Institute, Inc.
INDUSTRY